Corpus Intelligence IC Memo — FREDERICK MEMORIAL HOSPITAL 2026-04-26 05:28 UTC
IC Memo — FREDERICK MEMORIAL HOSPITAL
Investment Committee Memorandum | MD | 279 beds | Grade B | EBITDA uplift $28.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FREDERICK MEMORIAL HOSPITAL

CCN 210005 | FREDERICK, MD | 279 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

FREDERICK MEMORIAL HOSPITAL is a 279-bed suburban community hospital in FREDERICK, MD with $388.7M in net patient revenue and a -6.2% operating margin. The hospital serves a payer mix of 44.6% Medicare, 4.4% Medicaid, and 51.0% commercial.

Thesis: Undervalued. Our ML models identify $28.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.2% to 1.2% (+736bps).

Net Revenue HCRIS$388.7M
Current EBITDA COMPUTED$-24.0M
Operating Margin COMPUTED-6.2%
Occupancy HCRIS74.0%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS81.3%
Distress Probability ML49.4%

2. Market Context & Competitive Position

59
MD Hospitals
-8.3%
State Median Margin
31
Comparable Hospitals

MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -6.2% places it above the state median. Among 31 size-comparable peers (140-558 beds), the median margin is -9.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (140-558), prioritizing same-state peers. 31 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FREDERICK MEMORIAL HOSPITAL (Target)MD279$388.7M-6.2%
SINAI HOSPITAL OF BALTIMORE IMD459$820.9M-20.6%
JOHNS HOPKINS BAYVIEW MED. CTRMD424$654.4M-17.1%
ANNE ARUNDEL MEDICAL CENTER INMD379$616.6M-3.3%
MERCY MEDICAL CENTERMD173$561.3M-3.3%
MEDSTAR FRANKLIN SQUARE MEDICAMD354$537.6M-5.7%
HOLY CROSS HOSPITALMD399$516.0M-16.7%
ST. AGNES HOSPITALMD183$506.7M-12.2%
TIDALHEALTH PENINSULA REGIONALMD230$493.4M0.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $28.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$8.2M+210bp18mo
Cost to Collect4.5%2.5%$7.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.7M+122bp9mo
Clean Claim Rate88.0%96.0%$249K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$8.2M
Cost to Collect
$7.8M
Denial Rate Reduction
$7.7M
A/R Days Reduction
$4.7M
Clean Claim Rate
$249K
Total EBITDA Uplift$28.6M
Current EBITDA$-24.0M
+ RCM Uplift+$28.6M
Pro Forma EBITDA$4.6M
Current Margin-6.2%
Pro Forma Margin1.2%
WC Released (1x)$14.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-36.9M$127.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-36.9M$128.6M0.00x-100.0%
Bull Case9.0x11.0x$-33.2M$211.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-33.2M$220.4M0.00x-100.0%
Bear Case11.0x10.0x$-40.6M$-3.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-40.6M$-16.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 31 hospitals with 140-558 beds
  • Same-state prioritization (n=32)
  • Comp margins: P25=-14.6% / P50=-9.1% / P75=-3.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.